OmniVision: March 2026 Share Update Shows Stable H-Share Base, Minor A-Share Uptick from Options; Public Float at 4.02% Worth HK$5.37 Billion

Bulletin Express04-08

OmniVision Integrated Circuits Group, Inc. released its Monthly Return for Equity Issuer for the period ended 31 March 2026, outlining modest changes in registered capital and confirming compliance with Hong Kong’s public-float requirements. Key takeaways are as follows:

1. Authorised and Issued Share Capital • Registered share capital totalled RMB 1.26 billion (1,261.07 million shares at RMB 1 par value), unchanged month-on-month. • H-share quota remained flat at 50.74 million shares, while A-share authorisations increased marginally by 23,598 shares to 1.21 billion.

2. Share Issuance and Treasury Position • Issued H shares were unchanged at 50.74 million; no treasury H shares are outstanding. • Issued A shares rose by 23,598 to 1.20641 billion, reflecting option exercises. Treasury stock was steady at 3.92 million A shares.

3. Equity Incentive Activity • Two tranches of the 2023 stock-option plans added 23,598 new A shares during the month, generating RMB 1.84 million in proceeds. • Outstanding unexercised options under all incentive schemes total 28.91 million A shares, split across: – 2023 First Phase: 3.37 million options at RMB 78.01 exercise price – 2023 Second Phase: 5.55 million options at RMB 78.01 – 2025 Plan: 19.98 million options at RMB 138.67

4. Convertible Bonds • Convertible bonds due 27 December 2026 remain unchanged at RMB 2.43 billion, carrying a conversion price of RMB 159.12 per share and potentially issuable into 15.29 million A shares; no conversions occurred in March.

5. Public Float Confirmation • The company affirmed compliance with Main Board Rule 13.32D(1). H-share public float stood at 4.02%, equivalent to HK$5.37 billion in market value—well above the HK$1 billion threshold required for PRC issuers with additional listings.

The filing, submitted on 8 April 2026 by Joint Company Secretary Ren Bing, reports no share buy-backs, warrant activity, or HDR movements during the month. Overall, OmniVision’s capital structure remained broadly stable, with incremental dilution limited to option conversions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment